Literature DB >> 36268268

Pilot Study Comparing Adverse Cardiorespiratory Events among Pharmacologically and Nonpharmacologically Treated Infants Undergoing Monitoring for Neonatal Abstinence Syndrome.

Spoorthi Davala1, Aaron Hansbury2, Melissa Miller2, Jeffery Boateng2, Hira Shrestha3, Elisha M Wachman3.   

Abstract

There is variation in cardiorespiratory monitoring practices for neonatal abstinence syndrome. We examined the incidence of cardiorespiratory adverse events in infants with neonatal abstinence syndrome who were treated or nontreated pharmacologically. Eight (10%) in the nontreated and 23 (19%) in the treated group experienced adverse events. This warrants further investigation in a larger cohort.

Entities:  

Year:  2020        PMID： 36268268      PMCID： PMC9581337          DOI： 10.1016/j.ympdx.2020.100027

Source DB:  PubMed          Journal:  J Pediatr X        ISSN： 2590-0420


  16 in total

Review 1.  Evidence-based clinical guidelines on analgesia and sedation in newborn infants undergoing assisted ventilation and endotracheal intubation.

Authors:  Gina Ancora; Paola Lago; Elisabetta Garetti; Daniele Merazzi; Patrizia Savant Levet; Carlo Valerio Bellieni; Luisa Pieragostini; Anna Pirelli
Journal:  Acta Paediatr       Date:  2018-12-06       Impact factor: 2.299

2.  Impact of Parental Presence at Infants' Bedside on Neonatal Abstinence Syndrome.

Authors:  Mary Beth Howard; Davida M Schiff; Nicole Penwill; Wendy Si; Anjali Rai; Tahlia Wolfgang; James M Moses; Elisha M Wachman
Journal:  Hosp Pediatr       Date:  2017-02

Review 3.  The use of methadone to facilitate opioid weaning in pediatric critical care patients: a systematic review of the literature and meta-analysis.

Authors:  Leslie A Dervan; Beryl Yaghmai; Robert Scott Watson; Fredric M Wolf
Journal:  Paediatr Anaesth       Date:  2017-01-20       Impact factor: 2.556

4.  Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.

Authors:  Jonathan M Davis; Jeffrey Shenberger; Norma Terrin; Janis L Breeze; Mark Hudak; Elisha M Wachman; Peter Marro; Erica L Oliveira; Karen Harvey-Wilkes; Adam Czynski; Barbara Engelhardt; Karen D'Apolito; Debra Bogen; Barry Lester
Journal:  JAMA Pediatr       Date:  2018-08-01       Impact factor: 16.193

5.  Hospital Variation in Neonatal Abstinence Syndrome Incidence, Treatment Modalities, Resource Use, and Costs Across Pediatric Hospitals in the United States, 2013 to 2016.

Authors:  Carly E Milliren; Munish Gupta; Dionne A Graham; Patrice Melvin; Maria Jorina; Al Ozonoff
Journal:  Hosp Pediatr       Date:  2018-01

6.  Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.

Authors:  M S Brown; M J Hayes; L M Thornton
Journal:  J Perinatol       Date:  2014-10-30       Impact factor: 2.521

Review 7.  Neonatal abstinence syndrome.

Authors:  Prabhakar Kocherlakota
Journal:  Pediatrics       Date:  2014-08       Impact factor: 7.124

8.  Quality improvement initiative to improve inpatient outcomes for Neonatal Abstinence Syndrome.

Authors:  Elisha M Wachman; Matthew Grossman; Davida M Schiff; Barbara L Philipp; Susan Minear; Elizabeth Hutton; Kelley Saia; Fnu Nikita; Ahmad Khattab; Angela Nolin; Crystal Alvarez; Karan Barry; Ginny Combs; Donna Stickney; Jennifer Driscoll; Robin Humphreys; Judith Burke; Camilla Farrell; Hira Shrestha; Bonny L Whalen
Journal:  J Perinatol       Date:  2018-05-08       Impact factor: 2.521

Review 9.  A systematic review of the cardiotoxicity of methadone.

Authors:  Samira Alinejad; Toba Kazemi; Nasim Zamani; Robert S Hoffman; Omid Mehrpour
Journal:  EXCLI J       Date:  2015-05-05       Impact factor: 4.068

Review 10.  Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.

Authors:  Elisha M Wachman; Davida M Schiff; Michael Silverstein
Journal:  JAMA       Date:  2018-04-03       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.